How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – A Roadmap of Primary Pandemic Prevention Through Spillover Investigation – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Modeling Case Burden and Duration of Sudan Ebola Virus Disease Outbreak in Uganda, 2022 – Volume 31, Number 9—September 2025 – Emerging Infectious Diseases journal

Early Release – Mpox [em′poks] and Monkeypox Virus [muhng′kee poks′ vī-ruhs′] – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Crimean-Congo Hemorrhagic Fever Virus Africa 1 Lineage in Hyalomma dromedarii Ticks, Algeria, 2023 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Variance Among Public Health Agencies’ Boil Water Guidance – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Estimated COVID-19 Periodicity and Correlation with SARS-CoV-2 Spike Protein S1 Antigenic Diversity, United States – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Correction: Vol. 31, No. 6 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Recombinant Myxoma Virus in European Brown Hares, 2023–2024 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Progression from Candida auris Colonization Screening to Clinical Case Status, United States, 2016–2023 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Early Release – Correction: Vol. 30, No. 3 – Volume 31, Number 8—August 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us